Description

Join leading experts Fariha Abbasi-Feinberg, MD, FAASM, Medical Director of Sleep Medicine at Millennium Physician Group and President Elect for the American Academy of Sleep Medicine; Inderpreet K. Madahar, MD, MBBS, Assistant Professor of Endocrinology, Diabetes, and Metabolism at Corewell Health; and Sarah Nadeem, MD, FACE, Assistant Professor, Section of Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine, Houston, TX, as they discuss the complex relationship between obstructive and central sleep apnea and metabolic disorders such as obesity and type 2 diabetes.

Key topics include:

• Who should be screened for sleep apnea and the recommended screening tools
• First-line and adjunctive therapies for management
• The evolving role of multidisciplinary care
• How clinical practice is shifting with the recent FDA label expansion of tirzepatide (Zepbound®)
• When tirzepatide may be considered alongside or in place of CPAP, APAP, and BiPAP therapies

Tune in for practical insights to better identify, manage, and support patients at risk. This episode is made possible through a sponsorship from Lilly.